MétaCan
Menu
Retour à la cohorte
Enregistrement W4402528561 · doi:10.1093/aje/kwae297

Maro responds to “raising a high-pressure alarm about pediatric hypertension”

2024· article· en· W4402528561 sur OpenAlexfundno aff
Judith C. Maro

Notice bibliographique

RevueAmerican Journal of Epidemiology · 2024
Typearticle
Langueen
DomaineMedicine
ThématiqueHealthcare Technology and Patient Monitoring
Établissements canadiensnon disponible
Organismes subventionnairesFood and Drug AdministrationU.S. Food and Drug AdministrationHamilton Health Sciences FoundationU.S. Department of Health and Human Services
Mots-clésRaising (metalworking)MedicineALARMIntensive care medicineEngineeringMetallurgyMaterials science

Résumé

récupéré en direct d'OpenAlex

We thank Dr. Weiss1 for his thoughtful engagement with our article2 and particularly how to interpret the findings in the absence of additional measurement of persistent pediatric hypertension (ie, when children with initial findings of clinical hypertension or elevated blood pressure do not experience a subsequent return to normal blood pressure without antihypertensive treatment). Dr. Weiss acknowledges the well-documented underrecognition and underdiagnosis of pediatric hypertension3,-6 despite clinical practice guidelines7 that were streamlined and simplified to improve recognition. Our study2 adds to this literature but finds a clear difference in estimates between children who met the clinical requirements for pediatric hypertension based on blood pressure readings and those who received a coded diagnosis of hypertension in their electronic medical record. Additionally, those with diagnosed hypertension were uniformly less well, suggesting a diagnosis is only conferred at more advanced stages of hypertension. Why is this mismatch so important? Early identification of pediatric hypertension allows earlier intervention strategies for a disease course when much is gained by prevention. While data collected primarily for research may be ideal to design and test new strategies for potential interventions, these types of observational cohorts are few and far between. Real-world data (ie, data collected in routine care, not primarily intended for research) are relatively inexpensive to acquire and can accelerate our understanding of specific clinical areas. However, these data must be fit-for-purpose, and our comparison of clinical and billing data demonstrates meaningful gaps where the billing data do not reflect the clinical phenomenon. Dr. Weiss acknowledges similar findings in pediatric sepsis,8 and other authors have similar findings in adult sepsis9 and obesity.10 Imagine we were to attempt to design an early-stage intervention to reduce pediatric hypertension and we selected a pediatric cohort that met clinical requirements based on blood pressure readings or we selected a pediatric cohort with diagnosis codes. We would be talking about 2 pediatric populations with markedly different severity, but without studies such as ours,2 we might be unaware of the limitations in generalizability. Dr. Weiss suggests that the prevalence we estimated with clinical blood pressure readings is concerningly high and implies misclassification. We acknowledge that our study was likely to yield higher estimates compared with prior work11 based on our inability to limit to ambulatory visits. Moreover, Dr. Weiss is concerned with our treatment of multiple blood pressures recorded on the same day, which follows clinical guidelines that require the average blood pressure to be recorded.7 Dr. Weiss would have preferred that a sensitivity analysis with the lowest reading was included, and we agree that such a sensitivity analysis would have helped dispel concerns. However, clinical guidelines also require 3 distinct measure-days to declare any child hypertensive, guarding against the possibility of incorrect classification from temporary elevations either on the same day or among multiple visits. We do not believe that the magnitude of such potential misclassification changes our core findings: that clinical data yielded higher estimates of pediatric hypertension that rarely translated into administrative diagnoses of hypertension. Real-world data are not without limits. As Dr. Weiss points out, they cannot be used to evaluate measurement issues in pediatric hypertension that arise from using the incorrect blood pressure instrument or using the incorrect limb. However, they allow investigators to understand more than they would otherwise know, giving us opportunities to improve public health. We should use them with eyes wide open for both their strengths and limitations. This work was supported by the Food and Drug Administration through the Department of Health and Human Services (contract number HHSF223201400030I). None to declared.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,003
score de la tête « metaresearch » (Gemma)0,034
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,017
Score d'incertitude au seuil0,046

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0030,034
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0010,000
Études des sciences et des technologies0,0050,001
Communication savante0,0020,001
Science ouverte0,0020,003
Intégrité de la recherche0,0170,017
Charge utile insuffisante (le modèle a refusé de juger)0,0140,005

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,060
Tête enseignante GPT0,383
Écart entre enseignants0,322 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2024
Routes d'admission1
Résumé présentnon

Explorer davantage

Même revueAmerican Journal of EpidemiologyMême sujetHealthcare Technology and Patient MonitoringTravaux en français237 207